144 Participants Needed

Robotic Gait Training for Spinal Cord Injury

(DOOR SCI Trial)

AR
CO
FM
Overseen ByFaith Meza, MPH
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Baylor Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 4 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines how different amounts of robotic gait training (RGT) can help people with spinal cord injuries improve their walking ability. Researchers aim to determine if adding transcranial magnetic stimulation (TMS), a type of brain stimulation, enhances the training's effectiveness. Participants will receive varying frequencies of RGT sessions or standard care without robotics. The trial suits individuals with incomplete spinal cord injuries who are in the early stages of recovery and receiving care at a specific rehabilitation center. As an unphased trial, it offers a unique opportunity to contribute to pioneering research that could enhance rehabilitation techniques for spinal cord injuries.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that robotic gait training is safe for spinal cord injury patients?

Research shows that robotic gait training (RGT) is generally safe for people with spinal cord injuries. Studies have found that RGT can significantly improve daily activities, muscle strength, and walking abilities. A review of multiple studies found that this type of training can enhance the quality of life for those with spinal cord injuries, indicating it is well-tolerated.

Although the studies do not specifically focus on safety, they report no serious side effects. This suggests that RGT is relatively safe for most participants. For those considering joining a trial for robotic gait training, this research suggests a positive safety profile can be expected.12345

Why are researchers excited about this trial?

Researchers are excited about robotic gait training for spinal cord injury because it offers a high-tech approach to rehabilitation. Unlike standard physical therapy that relies on manual techniques, robotic gait training uses advanced robotics to simulate walking patterns with precision. This technology can provide consistent, repetitive motion, potentially leading to improved motor recovery. Additionally, by offering different frequencies of training sessions, the treatment can be tailored to fit individual needs, optimizing recovery outcomes. Overall, robotic gait training represents a promising advancement in enhancing mobility for those with spinal cord injuries.

What evidence suggests that robotic gait training is effective for spinal cord injury?

This trial will compare different frequencies of robotic gait training (RGT) with usual care gait training for individuals with spinal cord injuries. Studies have shown that RGT can significantly aid people with spinal cord injuries by easing daily activities, strengthening muscles, and enhancing walking. Research also indicates that RGT improves walking ability and ease of movement, promoting a healthier lifestyle. Additionally, RGT improves balance and muscle coordination. These benefits suggest that RGT could be a promising option for enhancing mobility in those with spinal cord injuries.12456

Who Is on the Research Team?

CS

Chad Swank, PhD, PT, NCS

Principal Investigator

Baylor Research Institute

Are You a Good Fit for This Trial?

This trial is for individuals with motor incomplete spinal cord injuries, in the acute or subacute recovery phase. Participants must be medically stable and receiving care at Baylor Scott & White Institute for Rehabilitation. They should fit within the Ekso robotic exoskeleton's size limits and manage bladder/bowel continence. Exclusions include severe TBI, degenerative conditions, cognitive impairments, pregnancy, or living over 90 miles from the institute.

Inclusion Criteria

I have an incomplete spinal cord injury that affects my movement.
You must fit within the size limits of the Ekso robotic exoskeleton.
I am receiving care at Baylor Scott & White Institute for Rehabilitation.
See 4 more

Exclusion Criteria

I have a condition that is getting progressively worse.
I have a moderate to severe brain injury.
You have a developmental disability, significant mental health diagnosis, or other thinking problems before the start of the study.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Inpatient Rehabilitation

Participants begin robotic gait training (RGT) during inpatient rehabilitation

6-12 weeks
Multiple sessions per week

Outpatient Rehabilitation

Continuation of RGT sessions in outpatient settings with varying frequency

6-12 weeks
2-4 sessions per week

Follow-up

Participants are monitored for safety and effectiveness after treatment

9 months
Periodic assessments at 1-month and 9-months post-SCI

What Are the Treatments Tested in This Trial?

Interventions

  • Robotic Gait Training
  • Usual Care (UC) Gait Training
Trial Overview The DOOR SCI study is testing how different amounts of robotic gait training (RGT) combined with transcranial magnetic stimulation (TMS) affect functional outcomes and brain changes after a spinal cord injury. This happens during inpatient rehab and continues into early outpatient care.
How Is the Trial Designed?
4Treatment groups
Experimental Treatment
Active Control
Group I: Moderate FrequencyExperimental Treatment1 Intervention
Group II: Low FrequencyExperimental Treatment1 Intervention
Group III: High FrequencyExperimental Treatment1 Intervention
Group IV: Control GroupActive Control1 Intervention

Robotic Gait Training is already approved in European Union, United States, Canada, Switzerland for the following indications:

🇪🇺
Approved in European Union as Robotic Assisted Gait Training for:
🇺🇸
Approved in United States as Robotic Assisted Gait Training for:
🇨🇦
Approved in Canada as Robotic Assisted Gait Training for:
🇨🇭
Approved in Switzerland as Robotic Assisted Gait Training for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Baylor Research Institute

Lead Sponsor

Trials
210
Recruited
205,000+

Texas Woman's University

Collaborator

Trials
90
Recruited
5,900+

United States Department of Defense

Collaborator

Trials
940
Recruited
339,000+

Texas Woman's University

Collaborator

Trials
1
Recruited
140+

Published Research Related to This Trial

In a study involving 12 patients with chronic spinal cord injury, both standard rehabilitation and robot-assisted gait training (RAGT) led to increased self-selected walking speed, indicating short-term efficacy in improving gait functions.
RAGT specifically contributed to a significant increase in step length, which was associated with improved hip flexor muscle function, highlighting its potential as a beneficial intervention in rehabilitation for SCI patients.
Gait training using a wearable robotic hip device for incomplete spinal cord injury: A preliminary study.Yoshikawa, K., Mutsuzaki, H., Koseki, K., et al.[2023]
In a study involving 15 spinal cord injury patients, overground robotic gait training (Ekso GT) required higher energy expenditure and cognitive effort compared to treadmill robotic training (Lokomat), indicating a more demanding rehabilitation process.
Despite the increased effort, both robotic systems were well-received by patients, with improvements in walking economy observed, suggesting that both methods can be effective in enhancing rehabilitation outcomes.
Energy cost and psychological impact of robotic-assisted gait training in people with spinal cord injury: effect of two different types of devices.Corbianco, S., Cavallini, G., Dini, M., et al.[2021]
A network meta-analysis of 12 studies involving 353 participants with spinal cord injury found that wearable exoskeleton-assisted walking (EAW) significantly improved walking distance and speed compared to Lokomat training.
While both Lokomat and EAW enhanced locomotor abilities, EAW showed a higher probability of improving walking speed, suggesting it may be a more effective option for enhancing locomotion in individuals with spinal cord injury.
Comparison of Efficacy of Lokomat and Wearable Exoskeleton-Assisted Gait Training in People With Spinal Cord Injury: A Systematic Review and Network Meta-Analysis.Zhang, L., Lin, F., Sun, L., et al.[2022]

Citations

Robot-Assisted Gait Training in Individuals With Spinal Cord ...This meta-analysis revealed that RAGT significantly improved activities of daily living, muscular strength, and walking abilities.
Review article Gait quality after robot therapy compared ...This systematic review compares the effectiveness of robot-assisted gait training (RAGT) with Lokomat® and OGT for individuals with spinal cord injury during ...
Robot-assisted gait training (Lokomat) improves walking ...RAGT treatment is a promising technique to restore functional walking and improve locomotor ability, which might enable SCI patients to maintain a healthy ...
The effect of robot-assisted gait training for patients with ...Robot-assisted gait training seems to be helpful for patients with spinal cord to improve TUG. It may not affect gait distance, gait speed, leg strength, 10 ...
Lokomat-Assisted Robotic Rehabilitation in Spinal Cord ...Lokomat-based therapy has improved biomechanical symmetry, muscular coordination, and psychological and quality-of-life outcomes in individuals with partial ...
Robot Assisted Gait Training in Persons With a Spinal Cord ...RAGT has emerged as a promising method for improving ambulation after spinal cord injury (SCI). Early reports of this therapy were very promising.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security